A PHP Error was encountered

Severity: Warning

Message: fopen(/home/oaponnap/tmp/ci_sessionceed728ac0e7de8690070ec4a8673fab): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 157

Backtrace:

File: /home/oaponnap/public_html/innovationinfo.org/application/controllers/Journalnew.php
Line: 8
Function: __construct

File: /home/oaponnap/public_html/innovationinfo.org/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /home/oaponnap/tmp)

Filename: Session/Session.php

Line Number: 141

Backtrace:

File: /home/oaponnap/public_html/innovationinfo.org/application/controllers/Journalnew.php
Line: 8
Function: __construct

File: /home/oaponnap/public_html/innovationinfo.org/index.php
Line: 315
Function: require_once

Feuerstein GZ, Firestein R, Marcinkiewicz C (2025) Development an Innovative, Contrarian and Unprecedented Theragnostic Technology based on Submicron Fluorescent Diamond Particles, FDP-NV-750NM Coated with Doxorubicin and Duplex Sorafenib. PART II: - In Vivo Proof of Hypotheses and Technical Feasibility for Direct to Tumor Injection of FDP-NV-DOX~SOR to Xenograft Tumors in Immune Compromised BALB/C2 ‘NUDE’ Mice. Int J Nano Rech Vol: 8, Issu: 1 (01-19).

Development an Innovative, Contrarian and Unprecedented Theragnostic Technology based on Submicron Fluorescent Diamond Particles, FDP-NV-750NM Coated with Doxorubicin and Duplex Sorafenib. PART II: - In Vivo Proof of Hypotheses and Technical Feasibil

Feuerstein GZ* , Firestein R, Marcinkiewicz C.

  • Name: Feuerstein GZ*
  • Phone: +1234567890
  • Country: United States of America
  • Received date: 02 February, 2025
  • Accepted date: 19 May, 2025
  • Published date: 26 May, 2025

Designation: FARMACON LLC, San Diego, California, USA

Citation: Feuerstein GZ, Firestein R, Marcinkiewicz C (2025) Development an Innovative, Contrarian and Unprecedented Theragnostic Technology based on Submicron Fluorescent Diamond Particles, FDP-NV-750NM Coated with Doxorubicin and Duplex Sorafenib. PART II: - In Vivo Proof of Hypotheses and Technical Feasibility for Direct to Tumor Injection of FDP-NV-DOX~SOR to Xenograft Tumors in Immune Compromised BALB/C2 ‘NUDE’ Mice. Int J Nano Rech Vol: 8, Issu: 1 (01-19).

Copyright: © 2025 Feuerstein GZ et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Fulltext Under Construction
Creative Commons Licence

This work is licensed under a
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright @ Innovation Info, All Rights Reserved.
Facebook
Twitter
LinkedIn